Voraxaze

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 50633-210
  • Package NDC 50633-210-11
  • Application number BLA125327
  • SPL ID 27e39e9a-42e0-fb03-e063-6394a90aae3e
  • SPL set ID acaef5a6-b740-40e3-8ffe-74a75c74745c
  • UNII 2GFP9BJD79
  • RxCUI 1242131
  • RxCUI 1242136

What the source publishes

Labeler
BTG International Inc.
Active ingredients
glucarpidase
Form
INJECTION, POWDER, FOR SOLUTION
Routes
INTRAVENOUS
Administrative status
present-in-source-snapshot
Marketing status
BLA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:50633-210_27e39e9a-42e0-fb03-e063-6394a90aae3e
{
  "name": "Voraxaze",
  "splId": "27e39e9a-42e0-fb03-e063-6394a90aae3e",
  "labels": [
    {
      "setId": "acaef5a6-b740-40e3-8ffe-74a75c74745c",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=acaef5a6-b740-40e3-8ffe-74a75c74745c",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=acaef5a6-b740-40e3-8ffe-74a75c74745c"
    }
  ],
  "routes": [
    "INTRAVENOUS"
  ],
  "labeler": "BTG International Inc.",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "1 VIAL in 1 CARTON (50633-210-11)  / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL",
      "package_ndc": "50633-210-11",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20120401"
    }
  ],
  "productId": "50633-210_27e39e9a-42e0-fb03-e063-6394a90aae3e",
  "useDomain": "unknown",
  "dosageForm": "INJECTION, POWDER, FOR SOLUTION",
  "productNdc": "50633-210",
  "deaSchedule": null,
  "genericName": "glucarpidase",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "GLUCARPIDASE",
      "strength": "1000 [USP'U]/1"
    }
  ],
  "applicationNumber": "BLA125327",
  "marketingCategory": "BLA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20120401",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000184013",
      "M0003411"
    ],
    "unii": [
      "2GFP9BJD79"
    ],
    "rxcui": [
      "1242131",
      "1242136"
    ],
    "spl_set_id": [
      "acaef5a6-b740-40e3-8ffe-74a75c74745c"
    ],
    "pharm_class_cs": [
      "Carboxypeptidases [CS]"
    ],
    "pharm_class_epc": [
      "Carboxypeptidase [EPC]"
    ],
    "manufacturer_name": [
      "BTG International Inc."
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20261231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:50633-210_27e39e9a-42e0-fb03-e063-6394a90aae3e"